ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Stock Cash Flow
NASDAQ:ADAP - Nasdaq - US00653A1079 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -69.89M | -70.81M | -113.87M | -165.46M | -158.09M | |||
| Depreciation Amortization | 10.86M | 11.22M | 9.84M | 6.08M | 6.57M | |||
| Change In Working Capital | -68.69M | -36.98M | -24.95M | -1.53M | 134.63M | |||
| Interest Paid | N/A | 2.09M | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 1.52M | 4.00M | 630.00K | 540.00K | |||
| Other non cash items | 19.87M | 23.36M | -11.90M | 19.14M | 27.62M | |||
| OPERATING CASH FLOW | -107.85M | -73.21M | -140.88M | -141.77M | 10.73M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.56M | -2.72M | -4.88M | -29.74M | -8.78M | |||
| Other Investing Activity | N/A | -56.23M | 181.42M | 118.88M | 84.58M | |||
| INVESTING CASH FLOW | -17.44M | -58.95M | 176.54M | 89.14M | 75.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 49.50M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 145.00K | 29.25M | 880.00K | 12.87M | 3.29M | |||
| FINANCING CASH FLOW | 24.19M | 78.75M | 880.00K | 12.87M | 3.29M | |||
| Exchange Rate Effect | 570.00K | -402.00K | 877.00K | -2.30M | 370.00K | |||
| CHANGE IN CASH | -100.52M | -53.81M | 37.41M | -42.06M | 90.19M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -107.85M | -73.21M | -140.88M | -141.77M | 10.73M | |||
| Capital Expenditure | -3.56M | -2.72M | -4.88M | -29.74M | -8.78M | |||
| FREE CASH FLOW | -111.41M | -75.93M | -145.76M | -171.51M | 1.95M | |||
All data in USD